1h Free Analyst Time
The Surgical Adhesives Market grew from USD 1.75 billion in 2024 to USD 1.92 billion in 2025. It is expected to continue growing at a CAGR of 9.65%, reaching USD 3.05 billion by 2030.Speak directly to the analyst to clarify any post sales queries you may have.
The surgical adhesives market has emerged as a critical component in modern operative practice, offering alternatives to traditional sutures and staples. As surgical teams strive for faster procedures and improved patient outcomes, adhesives reduce procedure time, minimize tissue trauma, and lower infection risks. Technological advances are expanding the range of applications from cardiovascular to orthopedic surgery, while ongoing research explores novel biomaterials and delivery systems. Regulatory bodies are also streamlining approval pathways, heightening the importance of stringent quality control and biocompatibility. This convergence of clinical demand, innovation, and regulatory evolution is reshaping how adhesives are selected and deployed in diverse surgical settings, underscoring their growing strategic value to healthcare providers.
Transformative Shifts Reshaping the Surgical Adhesives Landscape
Over the past decade, the landscape of surgical adhesives has undergone transformative shifts driven by minimally invasive techniques, robotic assistance, and patient-centric care models. Minimally invasive surgery is leveraging sealants designed for endoscopic delivery, while robotic platforms demand adhesives with rapid polymerization to maintain hemostasis in precise tissue manipulation. Concurrently, digital health solutions are enabling real-time monitoring of adhesive performance through smart delivery systems. Manufacturers are responding with next-generation formulations that combine hemostatic, antimicrobial, and regenerative properties. Furthermore, heightened emphasis on personalized medicine is fostering the development of bioengineered adhesives tailored to individual healing profiles. Together, these technological and clinical shifts are redefining product pipelines, procurement strategies, and training protocols across care teams.Cumulative Impact of United States Tariffs on Surgical Adhesives in 2025
In 2025, cumulative tariffs imposed on medical device imports have materially impacted the cost structure of surgical adhesives in the United States. Import duties on key raw components have driven manufacturers to reassess supply chains, prompting some to relocate production closer to North American facilities. End-users are facing upward price pressure as distributors pass through increased costs, potentially restricting access in budget-constrained hospitals and ambulatory centers. To mitigate these headwinds, several market participants are exploring localized sourcing partnerships and negotiating long-term contracts with tariff-exempt suppliers. Strategic inventory planning and investment in domestic manufacturing infrastructure are becoming essential measures to preserve margins and ensure product availability under evolving trade regulations.Key Segmentation Insights Driving Surgical Adhesives Adoption
A nuanced understanding of market segmentation provides actionable insights for stakeholders. Based on product analysis, collagen-based adhesives continue to enjoy preference in procedures requiring rapid bonding and tissue regeneration, while cyanoacrylate adhesives are valued for their accelerated polymerization and ease of use. Fibrin sealants remain integral in high-bleed environments, whereas hydrocolloid adhesives support wound management with prolonged adhesion under moisture. Silicone adhesives offer superior biocompatibility for sensitive tissue interfaces. Examining composition reveals that biological adhesives, leveraging natural polymers, are leading in applications demanding bioresorbability, while synthetic adhesives offer cost advantages and consistent performance. In surgical method, minimally invasive surgery is driving design for catheter-compatible formulations, and open surgery maintains demand for bulk sealants with broad coverage. Application segmentation highlights that cardiovascular surgery benefits from adhesives with hemostatic and anti-thrombotic features, whereas cosmetic surgery prioritizes formulations that minimize scarring. General surgery relies on versatile sealants across gastrointestinal procedures, and orthopedic surgery demands adhesives with high tensile strength. End-user dynamics show that ambulatory surgical centers seek fast-curing, low-cost options, hospitals and clinics require a balanced portfolio for multiple surgical departments, and specialty care centers invest in premium, procedure-specific adhesives to support high-complexity cases.Key Regional Insights Informing Market Participation
Regional dynamics shape competitive strategies and investment priorities. In the Americas, advanced healthcare infrastructure and favorable reimbursement frameworks underpin robust demand for innovative formulations, with the United States leading adoption of smart delivery systems. Latin America is showing increasing interest in cost-effective synthetic adhesives as governments expand surgical capacity. Across Europe, Middle East & Africa, Europe remains at the forefront of regulatory harmonization, enabling faster market entry for biologically derived adhesives. The Middle East is investing in specialty care centers, creating opportunities for premium sealants, while Africa’s developing markets are driven by affordability and supply reliability. In the Asia-Pacific, rapid expansion of hospital networks in China and India is stimulating volume growth, and Japan’s emphasis on minimally invasive procedures is fueling demand for endoscopic sealants. Regulatory agencies in the region are enhancing standards, encouraging global manufacturers to localize production and adapt formulations to regional clinical practices.Key Company Insights and Competitive Dynamics
Leading global and regional players are driving innovation across the surgical adhesives value chain. 3M Company continues to expand its portfolio with bioactive adhesives, while Advanced Medical Solutions Group PLC focuses on point-of-care delivery systems. Artivion, Inc and B. Braun Melsungen AG are enhancing their offerings through strategic acquisitions to integrate advanced hemostatic technologies. Baxter International Inc. and Becton, Dickinson, and Company leverage broad distribution networks to accelerate access to new formulations. Cardinal Health, Inc. and Chemence Medical, Inc. invest heavily in R&D to develop dual-component adhesives for complex tissue repair. Connexicon Medical Limited and CSL Behring AG collaborate on regenerative sealants enhanced with growth factors. GEM S.r.l. and GluStitch Inc. pilot bioadhesives with antimicrobial properties, while Grena Ltd. and H.B. Fuller Company drive process innovations to lower production costs. Henkel AG & Co. KGaA and Integra LifeSciences Holdings Corporation are pioneering synthetic-biological hybrid adhesives. Johnson & Johnson Services, Inc. alongside Kuraray America, Inc. optimize global clinical trials for novel cyanoacrylates. Medline Industries, LP and Medtronic PLC expand their footprints through distribution partnerships. Meyer-Haake GmbH Medical Innovations and Mitsui Chemicals, Inc. explore cross-industry collaboration for smart polymers. Nordson Corporation and Sealantis Ltd. invest in precision delivery hardware to enhance on-site usability, and UFP Technologies Inc. with Vivostat A/S advance point-of-care blood-derived fibrin systems. Collectively, these players are shaping market trajectories through M&A, co-development agreements, and targeted innovation pipelines.Actionable Recommendations for Industry Leaders
Industry leaders can harness several strategic levers to drive growth and resilience. First, investing in advanced biocompatible formulations that combine hemostatic, antimicrobial, and regenerative functionalities will meet evolving clinical needs. Second, embracing digital health integration-such as smart applicators with data analytics-can differentiate offerings and support value-based care models. Third, building supply chain agility by diversifying raw material sources and establishing regional manufacturing hubs will mitigate tariff and logistics risks. Fourth, fostering cross-sector partnerships with medical device OEMs, healthcare providers, and academic institutions will accelerate co-innovation and clinical adoption. Finally, expanding presence in high-growth emerging markets through localized clinical studies and pricing strategies will unlock new revenue streams while reinforcing global market leadership.Conclusion: Charting a Path Forward in Surgical Adhesives
As the surgical adhesives market continues to advance, stakeholders must navigate a complex interplay of technological innovation, regulatory evolution, and geopolitical influences. By aligning product development with minimally invasive and digital health trends, companies can capture premium segments. Proactive supply chain management and regional manufacturing investments will safeguard margins amid trade uncertainties. In parallel, deepening collaboration with clinical experts and end-users will ensure that formulations and delivery systems address real-world challenges. Ultimately, the capacity to adapt swiftly while maintaining rigorous quality standards will determine competitive positioning and long-term value creation in this dynamic landscape.Market Segmentation & Coverage
This research report categorizes the Surgical Adhesives Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Collagen-Based Adhesives
- Cyanoacrylate Adhesives
- Fibrin Sealants
- Hydrocolloid Adhesives
- Silicone Adhesives
- Biological Adhesives
- Synthetic Adhesives
- Minimally Invasive Surgery
- Open Surgery
- Cardiovascular Surgery
- Cosmetic Surgery
- General Surgery
- Orthopedic Surgery
- Ambulatory Surgical Centers
- Hospitals & Clinics
- Specialty Care Centers
This research report categorizes the Surgical Adhesives Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Surgical Adhesives Market to delves into recent significant developments and analyze trends in each of the following companies:
- 3M Company
- Advanced Medical Solutions Group PLC
- Artivion, Inc
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson, and Company
- Cardinal Health, Inc.
- Chemence Medical, Inc.
- Connexicon Medical Limited
- CSL Behring AG
- GEM S.r.l.
- GluStitch Inc.
- Grena Ltd.
- H.B. Fuller Company
- Henkel AG & Co. KGaA
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson Services, Inc.
- Kuraray America, Inc.
- Medline Industries, LP
- Medtronic PLC
- Meyer-Haake GmbH Medical Innovations
- Mitsui Chemicals, Inc.
- Nordson Corporation
- Sealantis Ltd.
- UFP Technologies Inc.
- Vivostat A/S
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
6. Market Insights
8. Surgical Adhesives Market, by Product
9. Surgical Adhesives Market, by Composition
10. Surgical Adhesives Market, by Surgical Method
11. Surgical Adhesives Market, by Application
12. Surgical Adhesives Market, by End-User
13. Americas Surgical Adhesives Market
14. Asia-Pacific Surgical Adhesives Market
15. Europe, Middle East & Africa Surgical Adhesives Market
16. Competitive Landscape
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
List of Tables
Companies Mentioned
- 3M Company
- Advanced Medical Solutions Group PLC
- Artivion, Inc
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson, and Company
- Cardinal Health, Inc.
- Chemence Medical, Inc.
- Connexicon Medical Limited
- CSL Behring AG
- GEM S.r.l.
- GluStitch Inc.
- Grena Ltd.
- H.B. Fuller Company
- Henkel AG & Co. KGaA
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson Services, Inc.
- Kuraray America, Inc.
- Medline Industries, LP
- Medtronic PLC
- Meyer-Haake GmbH Medical Innovations
- Mitsui Chemicals, Inc.
- Nordson Corporation
- Sealantis Ltd.
- UFP Technologies Inc.
- Vivostat A/S
Methodology
LOADING...
